0001799191-22-000050.txt : 20221122
0001799191-22-000050.hdr.sgml : 20221122
20221122200722
ACCESSION NUMBER: 0001799191-22-000050
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221115
FILED AS OF DATE: 20221122
DATE AS OF CHANGE: 20221122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hively Brad
CENTRAL INDEX KEY: 0001891124
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39248
FILM NUMBER: 221412005
MAIL ADDRESS:
STREET 1: C/O THE ONCOLOGY INSTITUTE OF HOPE
STREET 2: 18000 STUDEBAKER ROAD, SUITE 800
CITY: CERRITOS
STATE: CA
ZIP: 90703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncology Institute, Inc.
CENTRAL INDEX KEY: 0001799191
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18000 STUDEBAKER RD
STREET 2: SUITE 800
CITY: CERRITOS
STATE: CA
ZIP: 90703
BUSINESS PHONE: 562-735-3226
MAIL ADDRESS:
STREET 1: 18000 STUDEBAKER RD
STREET 2: SUITE 800
CITY: CERRITOS
STATE: CA
ZIP: 90703
FORMER COMPANY:
FORMER CONFORMED NAME: DFP HEALTHCARE ACQUISITIONS CORP.
DATE OF NAME CHANGE: 20200108
4/A
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4/A
2022-11-15
2022-11-17
0
0001799191
Oncology Institute, Inc.
TOI
0001891124
Hively Brad
C/O THE ONCOLOGY INSTITUTE INC.
18000 STUDEBAKER RD, SUITE 800
CERRITOS
CA
90703
0
1
0
0
Chief Executive Officer
Common Stock
2022-11-15
4
S
0
9718
2.0278
D
452201
D
This Form 4/A amends and restates the reporting persons Form 4 originally filed on November 17, 2022 in the entirety. This Form 4/A is being filed to correct the reporting persons original Form 4 from Code D to Code S. The sales reported in the Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
Price is the volume weighted average selling price of all sales by the Reporting Person on November 15, 2022 within a one-dollar range. Actual prices ranged from $2.025 to $2.028. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
By: Mark Hueppelsheuser For: Brad Hively
2022-11-22